Variant report

Variant	nsv978431
Chromosome Location	chr17:45146826-45151336
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr17:45148562-45148592	K562	blood:	n/a	n/a
2	BHLHE40	chr17:45147784-45147837	A549	lung:	n/a	n/a
3	BRCA1	chr17:45147769-45147988	Hela-S3	cervix:	n/a	n/a
4	CBX3	chr17:45148405-45148864	K562	blood:	n/a	n/a
5	CEBPB	chr17:45147660-45147980	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr17:45147780-45147886	A549	lung:	n/a	n/a
7	CEBPB	chr17:45148891-45149068	K562	blood:	n/a	n/a
8	CHD2	chr17:45147684-45147884	Hela-S3	cervix:	n/a	n/a
9	CTCF	chr17:45148966-45149048	Lung_OC	lung:	n/a	n/a
10	CTCF	chr17:45148689-45148749	Lung_OC	lung:	n/a	n/a
11	CTCF	chr17:45150244-45150290	GM20000	blood:	n/a	n/a
12	CTCF	chr17:45148934-45148954	GM20000	blood:	n/a	n/a
13	EBF1	chr17:45150079-45150484	GM12878	blood:	n/a	n/a
14	ELF1	chr17:45148528-45148929	K562	blood:	n/a	chr17:45148709-45148722 chr17:45148733-45148746
15	EP300	chr17:45150286-45150540	SK-N-SH_RA	brain:	n/a	n/a
16	EP300	chr17:45148550-45148629	K562	blood:	n/a	n/a
17	EP300	chr17:45147634-45147904	Hela-S3	cervix:	n/a	chr17:45147822-45147831
18	FOS	chr17:45147620-45148016	MCF10A-Er-Src	breast:	n/a	chr17:45147822-45147831 chr17:45147820-45147831
19	FOS	chr17:45147619-45148012	MCF10A-Er-Src	breast:	n/a	chr17:45147822-45147831 chr17:45147820-45147831
20	FOS	chr17:45147600-45148019	MCF10A-Er-Src	breast:	n/a	chr17:45147822-45147831 chr17:45147820-45147831
21	FOS	chr17:45147647-45147995	HUVEC	blood vessel:	n/a	chr17:45147822-45147831 chr17:45147820-45147831
22	FOS	chr17:45147600-45148016	MCF10A-Er-Src	breast:	n/a	chr17:45147822-45147831 chr17:45147820-45147831
23	FOSL2	chr17:45147513-45148119	A549	lung:	n/a	chr17:45147822-45147831
24	FOSL2	chr17:45147614-45147982	HepG2	liver:	n/a	chr17:45147822-45147831
25	FOSL2	chr17:45147666-45147968	A549	lung:	n/a	chr17:45147822-45147831
26	GABPA	chr17:45148534-45148934	K562	blood:	n/a	n/a
27	GABPA	chr17:45148637-45148896	MCF-7	breast:	n/a	n/a
28	GABPA	chr17:45148545-45148921	K562	blood:	n/a	n/a
29	GABPA	chr17:45148508-45148850	Hela-S3	cervix:	n/a	n/a
30	GABPA	chr17:45148620-45148777	Hela-S3	cervix:	n/a	n/a
31	GATA2	chr17:45148778-45149141	K562	blood:	n/a	n/a
32	GTF2F1	chr17:45147597-45147925	Hela-S3	cervix:	n/a	n/a
33	JUN	chr17:45147640-45148005	Hela-S3	cervix:	n/a	chr17:45147822-45147831
34	JUND	chr17:45147674-45147975	HepG2	liver:	n/a	chr17:45147822-45147831 chr17:45147820-45147831
35	JUND	chr17:45147625-45148212	SK-N-SH	brain:	n/a	chr17:45147822-45147831 chr17:45147820-45147831
36	JUND	chr17:45147746-45147900	K562	blood:	n/a	chr17:45147822-45147831 chr17:45147820-45147831
37	JUND	chr17:45147664-45147925	HepG2	liver:	n/a	chr17:45147822-45147831 chr17:45147820-45147831
38	JUND	chr17:45147611-45148016	Hela-S3	cervix:	n/a	chr17:45147822-45147831 chr17:45147820-45147831
39	MAFK	chr17:45147640-45147975	Hela-S3	cervix:	n/a	chr17:45147823-45147832
40	MAX	chr17:45147648-45147898	Hela-S3	cervix:	n/a	chr17:45147822-45147831
41	MAX	chr17:45148624-45148767	NB4	blood:	n/a	n/a
42	MXI1	chr17:45147659-45147834	Hela-S3	cervix:	n/a	n/a
43	MYC	chr17:45147610-45147980	MCF10A-Er-Src	breast:	n/a	chr17:45147822-45147831
44	MYC	chr17:45147610-45147859	MCF10A-Er-Src	breast:	n/a	chr17:45147822-45147831
45	NR2F2	chr17:45148658-45149140	K562	blood:	n/a	n/a
46	NR2F2	chr17:45148802-45149145	K562	blood:	n/a	n/a
47	POLR2A	chr17:45151218-45151225	H1-hESC	embryonic stem cell:	n/a	n/a
48	POLR2A	chr17:45146813-45147049	GM12878	blood:	n/a	n/a
49	POLR2A	chr17:45147681-45147993	Hela-S3	cervix:	n/a	n/a
50	POLR2A	chr17:45147641-45148065	Hela-S3	cervix:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr17:45148479..45151206-chr17:45175479..45177922,2	K562	blood:
2	chr17:45145658..45148463-chr17:45161187..45163786,2	MCF-7	breast:
3	chr17:45142727..45145152-chr17:45150394..45151973,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RPRML-3	chr17:45149838-45149925	ENSG00000262879.1
2	lnc-RPRML-3	chr17:45149838-45149925	NONHSAT054277
3	lnc-RPRML-3	chr17:45148881-45148978	NONHSAT054277
4	lnc-RPRML-3	chr17:45149723-45149925	NONHSAT054278

Variant related genes	Relation type
ENSG00000262879	TF binding region
ENSG00000262879	chromatin interactions

Extended variants
information (count: 145 )
Associated
traits (count: 119 )

Variant overlapped rSNPs/rCNVs (count:145 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs112188019	chr17:45146839-45146840	Weak transcription Enhancers Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	mRNA abundance
2	rs115264153	chr17:45146853-45146854	Weak transcription Enhancers Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs562307219	chr17:45146884-45146885	Weak transcription Enhancers Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs182871919	chr17:45146893-45146894	Weak transcription Enhancers Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs543467751	chr17:45146904-45146905	Weak transcription Enhancers Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs148838094	chr17:45146958-45146959	Weak transcription Enhancers Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs531944773	chr17:45146999-45147000	Weak transcription Enhancers Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs551737319	chr17:45147106-45147107	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs558950559	chr17:45147109-45147110	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs528365200	chr17:45147128-45147129	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs548228101	chr17:45147141-45147142	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs146959606	chr17:45147251-45147252	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs536857004	chr17:45147324-45147325	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs147559212	chr17:45147416-45147417	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs116013586	chr17:45147421-45147422	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs374588169	chr17:45147522-45147523	Weak transcription Enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs539973238	chr17:45147529-45147530	Weak transcription Enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs550356555	chr17:45147631-45147632	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs555089409	chr17:45147633-45147634	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs2002537	chr17:45147686-45147687	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
21	rs543949170	chr17:45147739-45147740	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs111958058	chr17:45147807-45147808	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	mRNA abundance
23	rs147108084	chr17:45147812-45147813	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs142021311	chr17:45147915-45147916	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs575750668	chr17:45147970-45147971	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs57418075	chr17:45147986-45147987	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs559745892	chr17:45147988-45147989	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs111810157	chr17:45148038-45148039	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	mRNA abundance
29	rs113317500	chr17:45148093-45148094	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	mRNA abundance
30	rs545539254	chr17:45148095-45148096	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs558913699	chr17:45148109-45148110	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs528083723	chr17:45148148-45148149	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs560609776	chr17:45148149-45148150	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs531412001	chr17:45148150-45148151	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs374828690	chr17:45148228-45148229	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs7221149	chr17:45148258-45148259	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs561856037	chr17:45148259-45148260	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs370685459	chr17:45148315-45148316	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs549922392	chr17:45148368-45148369	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs188767344	chr17:45148390-45148391	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs570688540	chr17:45148452-45148453	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs533462674	chr17:45148557-45148558	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs113654961	chr17:45148569-45148570	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs547158760	chr17:45148648-45148649	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs62073858	chr17:45148669-45148670	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
46	rs535487547	chr17:45148701-45148702	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs117651629	chr17:45148729-45148730	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs117003760	chr17:45148746-45148747	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs192656245	chr17:45148782-45148783	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs34578303	chr17:45148798-45148799	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:119)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Melanoma	18172304	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell lymphomas	19863542	CNVD
Cancer	16751803	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Breast cancer	17457667	CNVD
Breast cancer	16951389	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	22048815	CNVD
Breast cancer	17603634	CNVD
Follicular lymphoma	20505157	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	20953835	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
TAR Syndrome	17847015	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17850661	CNVD
Breast cancer	19261255	CNVD
Lung cancer	16773561	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Basal-like breast cancer	18066063	CNVD
Breast cancer	20031965	CNVD
Colorectal cancer	19287155	CNVD
Hereditary breast	19566914	CNVD
Ovarian cancer	19047089	CNVD
Ovarian cancer	19566914	CNVD
Triple-negative breast cancer	18950515	CNVD
Breast cancer	16846527	CNVD
Bladder cancer	21909424	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	18628472	CNVD
Glioblastoma multiforme	18628472	CNVD
Leukemia	18628472	CNVD
Acute myeloid leukemia	21251322	CNVD
Ewing''s sarcoma	22429812	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21509527	CNVD
Urothelial carcinoma	21177765	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Breast cancer	17142309	CNVD
Breast cancer	16397240	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	17217626	CNVD
Non-syndromic sensorineural hearing loss	21084979	CNVD
Autism	22817714	CNVD
Breast cancer	20409316	CNVD
Cancer	17160897	CNVD
Frontotemporal lobar degeneration	19640594	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:236 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:45145000-45147200	Weak transcription	Primary monocytes fromperipheralblood	blood
2	chr17:45145000-45147200	Weak transcription	NH-A	brain
3	chr17:45145000-45147200	Weak transcription	NHDF-Ad	bronchial
4	chr17:45145000-45147400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
5	chr17:45145000-45147400	Weak transcription	Stomach Mucosa	stomach
6	chr17:45145000-45147400	Weak transcription	K562	blood
7	chr17:45145000-45147400	Weak transcription	Osteobl	bone
8	chr17:45145000-45147600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
9	chr17:45145000-45147800	Weak transcription	Fetal Thymus	thymus
10	chr17:45145000-45148000	Weak transcription	Liver	Liver
11	chr17:45145000-45148000	Weak transcription	Duodenum Mucosa	Duodenum
12	chr17:45145000-45148200	Weak transcription	Primary B cells from peripheral blood	blood
13	chr17:45145000-45148200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr17:45145000-45148200	Weak transcription	Fetal Muscle Trunk	muscle
15	chr17:45145000-45148400	Weak transcription	Adipose Nuclei	Adipose
16	chr17:45145000-45148400	Weak transcription	Colonic Mucosa	Colon
17	chr17:45145000-45148600	Weak transcription	Primary T cells fromperipheralblood	blood
18	chr17:45145000-45148600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
19	chr17:45145000-45148600	Weak transcription	Primary T helper cells PMA-I stimulated	--
20	chr17:45145000-45148600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
21	chr17:45145000-45148600	Weak transcription	Left Ventricle	heart
22	chr17:45145000-45148800	Weak transcription	Fetal Intestine Large	intestine
23	chr17:45145000-45149400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
24	chr17:45145000-45149400	Weak transcription	Fetal Stomach	stomach
25	chr17:45145000-45149400	Weak transcription	Ovary	ovary
26	chr17:45145000-45149400	Weak transcription	Sigmoid Colon	Sigmoid Colon
27	chr17:45145000-45149800	Weak transcription	Spleen	Spleen
28	chr17:45145000-45150000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
29	chr17:45145000-45150000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
30	chr17:45145000-45150000	Weak transcription	Esophagus	oesophagus
31	chr17:45145000-45150000	Weak transcription	HSMM	muscle
32	chr17:45145000-45150200	Weak transcription	Brain Cingulate Gyrus	brain
33	chr17:45145000-45150200	Weak transcription	Brain Hippocampus Middle	brain
34	chr17:45145000-45151600	Weak transcription	Psoas Muscle	Psoas
35	chr17:45145000-45152200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
36	chr17:45145000-45152400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr17:45145000-45158800	Weak transcription	NHLF	lung
38	chr17:45145000-45163600	Weak transcription	Aorta	Aorta
39	chr17:45145000-45163800	Weak transcription	Small Intestine	intestine
40	chr17:45145000-45164600	Weak transcription	Brain Angular Gyrus	brain
41	chr17:45145000-45169800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
42	chr17:45145000-45169800	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
43	chr17:45145000-45169800	Weak transcription	Fetal Lung	lung
44	chr17:45145000-45176400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
45	chr17:45145000-45176600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
46	chr17:45145000-45176800	Weak transcription	Lung	lung
47	chr17:45145200-45147000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
48	chr17:45145200-45147200	Weak transcription	Muscle Satellite Cultured Cells	--
49	chr17:45145200-45147200	Weak transcription	Monocytes-CD14+_RO01746	blood
50	chr17:45145200-45147400	Weak transcription	HUVEC	blood vessel

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links